In the march presentation under the fully implantable heading it mentions
Opens up new market for stable angina patients
-
~ 1M/yr in U.S
Why doesnt the current c-pulse system target this large market , will they need to do separate trials for angina. Didnt realise but there is stable and unstable angina.
http://www.nlm.nih.gov/medlineplus/ency/article/000198.htm
Add to My Watchlist
What is My Watchlist?